A partnership between diagnostics company, QIAGEN, and Health Innovation Manchester will develop a genomics and diagnostics campus in the city.
This new campus is set to attract companies from across the world to the north west, while the company has confirmed it is going to expand its current operations in Manchester, creating up to 800 skilled jobs.
CEO of QIAGEN, Peer M. Schatz said: “We are very excited about this partnership with Health Innovation Manchester, and the essential engagement of the University of Manchester, the NHS Trust and the UK government.
“Our success together can advance science and improve the lives of patients in the local region as well as worldwide.”
It has also been announced today that MSD, known as Merck in the US and Canada, will establish a new life-sciences research facility in the UK, supporting 950 highly skilled jobs.
The two investments are believed to have a combined investment value of more than £1bn.
Business Secretary Greg Clark said that other investments will follow in the £64bn life-sciences industry.
His announcement will come as he reveals a strategy to revive the UK’s productivity ahead of Brexit.
Our BQ Bulletin emails will land in your inbox at 7.30am, Monday to Friday, with a mix of the latest local business news, national news, and features to inspire you. Sign up here!
Click here to read our privacy statement